Suppr超能文献

Targeted nanotherapeutics in cancer.

作者信息

Shiekh Farooq A

机构信息

Avalon University School of Medicine, Curaçao, Netherlands Antilles.

出版信息

Int J Nanomedicine. 2014 Mar 26;9:1627-8. doi: 10.2147/IJN.S62468. eCollection 2014.

Abstract
摘要

相似文献

1
Targeted nanotherapeutics in cancer.
Int J Nanomedicine. 2014 Mar 26;9:1627-8. doi: 10.2147/IJN.S62468. eCollection 2014.
2
Mesoporous silica nanoparticles: a potential targeted delivery vector for reproductive biology?
Nanomedicine (Lond). 2014 Apr;9(5):557-60. doi: 10.2217/nnm.14.18.
3
[Beating cancer with synthetic genes: towards more effective treatments through autonomous genetic programs].
Med Sci (Paris). 2017 Jun-Jul;33(6-7):591-593. doi: 10.1051/medsci/20173306011. Epub 2017 Jul 19.
4
Tumour-agnostic therapies.
Nat Rev Drug Discov. 2020 Jun;19(6):383-384. doi: 10.1038/d41573-020-00015-1.
5
The Future of Precision Medicine in Oncology.
Clin Lab Med. 2016 Sep;36(3):557-73. doi: 10.1016/j.cll.2016.05.003.
6
[The future of new therapies in clinical medicine].
Med Clin (Barc). 2011 Nov 26;137(14):645-9. doi: 10.1016/j.medcli.2010.12.005. Epub 2011 Mar 11.
7
Toward personalized cancer nanomedicine - past, present, and future.
Integr Biol (Camb). 2013 Jan;5(1):48-65. doi: 10.1039/c2ib20104f.
8
Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Curr Cancer Drug Targets. 2018;18(4):337-346. doi: 10.2174/1568009617666170630141931.
9
Nanomedicine for the treatment of triple-negative breast cancer.
Nanomedicine (Lond). 2014 Apr;9(5):561-4. doi: 10.2217/nnm.14.19.
10
[Translational research - towards personalized medicine].
Nihon Yakurigaku Zasshi. 2013 Mar;141(3):122-5. doi: 10.1254/fpj.141.122.

引用本文的文献

1
Editor's choice: recent research highlights from the International Journal of Nanomedicine.
Int J Nanomedicine. 2017 Jun 19;12:4505-4508. doi: 10.2147/IJN.S140083. eCollection 2017.
2
Research highlights from the International Journal of Nanomedicine 2014.
Int J Nanomedicine. 2015 Mar 31;10:2503-5. doi: 10.2147/IJN.S81085. eCollection 2015.

本文引用的文献

1
A general framework for estimating the relative pathogenicity of human genetic variants.
Nat Genet. 2014 Mar;46(3):310-5. doi: 10.1038/ng.2892. Epub 2014 Feb 2.
3
Cancer as a metabolic disease: implications for novel therapeutics.
Carcinogenesis. 2014 Mar;35(3):515-27. doi: 10.1093/carcin/bgt480. Epub 2013 Dec 16.
4
In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools.
ACS Nano. 2014 Jan 28;8(1):175-87. doi: 10.1021/nn402669w. Epub 2013 Dec 16.
5
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.
J Control Release. 2014 Jan 28;174:195-201. doi: 10.1016/j.jconrel.2013.11.023. Epub 2013 Dec 5.
6
Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy.
J Control Release. 2014 Jan 28;174:137-42. doi: 10.1016/j.jconrel.2013.11.019. Epub 2013 Nov 23.
7
PEGylation improves the receptor-mediated transfection efficiency of peptide-targeted, self-assembling, anionic nanocomplexes.
J Control Release. 2014 Jan 28;174:177-87. doi: 10.1016/j.jconrel.2013.11.014. Epub 2013 Nov 22.
9
High-throughput methods for combinatorial drug discovery.
Sci Transl Med. 2013 Oct 2;5(205):205rv1. doi: 10.1126/scitranslmed.3006667.
10
Tumour heterogeneity.
Nature. 2013 Sep 19;501(7467):327. doi: 10.1038/501327a.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验